Immune Evasion and Provocation by Mycobacterium Tuberculosis

Overview

Journal Nat Rev Microbiol

Specialties Infectious Diseases
Microbiology

Date 2022 Jul 25

PMID 35879556

Authors

Pallavi Chandra

Steven J Grigsby

Jennifer A Philips

Affiliations

Soon will be listed here.

Abstract

Mycobacterium tuberculosis, the causative agent of tuberculosis, has infected humans for millennia. M. tuberculosis is well adapted to establish infection, persist in the face of the host immune response and be transmitted to uninfected individuals. Its ability to complete this infection cycle depends on it both evading and taking advantage of host immune responses. The outcome of M. tuberculosis infection is often a state of equilibrium characterized by immunological control and bacterial persistence. Recent data have highlighted the diverse cell populations that respond to M. tuberculosis infection and the dynamic changes in the cellular and intracellular niches of M. tuberculosis during the course of infection. M. tuberculosis possesses an arsenal of protein and lipid effectors that influence macrophage functions and inflammatory responses; however, our understanding of the role that specific bacterial virulence factors play in the context of diverse cellular reservoirs and distinct infection stages is limited. In this Review, we discuss immune evasion and provocation by M. tuberculosis during its infection cycle and describe how a more detailed molecular understanding is crucial to enable the development of novel host-directed therapies, disease biomarkers and effective vaccines.

Citing Articles

Alveolar macrophages from persons with HIV mount impaired TNF signaling networks to M. tuberculosis infection.

Kgoadi K, Bajpai P, Ibegbu C, Dkhar H, Enriquez A, Dawa S Nat Commun. 2025; 16(1):2397.

PMID: 40064940 PMC: 11894076. DOI: 10.1038/s41467-025-57668-y.

A new strategy improving TB diagnosis: stratified urine LAM test based on lymphocyte counts.

Li H, Gao X, Liu D, Li Z, Li J Front Cell Infect Microbiol. 2025; 15:1498651.

PMID: 40051710 PMC: 11882560. DOI: 10.3389/fcimb.2025.1498651.

The immunometabolic topography of tuberculosis granulomas governs cellular organization and bacterial control.

McCaffrey E, Delmastro A, Fitzhugh I, Ranek J, Douglas S, Peters J bioRxiv. 2025; .

PMID: 40027668 PMC: 11870603. DOI: 10.1101/2025.02.18.638923.

Nanobiosensors Enable High-Efficiency Detection of Tuberculosis Nucleic Acid.

Li M, Shen C, Lv M, Luo Y JACS Au. 2025; 5(2):536-549.

PMID: 40017783 PMC: 11862950. DOI: 10.1021/jacsau.4c01206.

MMP expression and its clinical significance in intervertebral disc destruction of spinal tuberculosis, Brucellar spondylitis, and pyogenic spondylitis.

Gao Y, Ma X, Shi Z, Zhu M, Yang Z, Tao Z J Orthop Surg Res. 2025; 20(1):208.

PMID: 40016774 PMC: 11866808. DOI: 10.1186/s13018-025-05622-5.

References

Goletti D, Lee M, Wang J, Walter N, Ottenhoff T . Update on tuberculosis biomarkers: From correlates of risk, to correlates of active disease and of cure from disease. Respirology. 2018; 23(5):455-466. DOI: 10.1111/resp.13272. View

Nair V, Franco L, Zacharia V, Khan H, Stamm C, You W . Microfold Cells Actively Translocate Mycobacterium tuberculosis to Initiate Infection. Cell Rep. 2016; 16(5):1253-1258. PMC: 4972672. DOI: 10.1016/j.celrep.2016.06.080. View

Shi L, Salamon H, Eugenin E, Pine R, Cooper A, Gennaro M . Infection with Mycobacterium tuberculosis induces the Warburg effect in mouse lungs. Sci Rep. 2015; 5:18176. PMC: 4674750. DOI: 10.1038/srep18176. View

Smith C, Baker R, Proulx M, Mishra B, Long J, Park S . Host-pathogen genetic interactions underlie tuberculosis susceptibility in genetically diverse mice. Elife. 2022; 11. PMC: 8846590. DOI: 10.7554/eLife.74419. View

Nebenzahl-Guimaraes H, van Laarhoven A, Farhat M, Koeken V, Mandemakers J, Zomer A . Transmissible Mycobacterium tuberculosis Strains Share Genetic Markers and Immune Phenotypes. Am J Respir Crit Care Med. 2016; 195(11):1519-1527. PMC: 5803666. DOI: 10.1164/rccm.201605-1042OC. View

Tameris M, Hatherill M, Landry B, Scriba T, Snowden M, Lockhart S . Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet. 2013; 381(9871):1021-8. PMC: 5424647. DOI: 10.1016/S0140-6736(13)60177-4. View

Pradhan G, Shrivastva R, Mukhopadhyay S . Mycobacterial PknG Targets the Rab7l1 Signaling Pathway To Inhibit Phagosome-Lysosome Fusion. J Immunol. 2018; 201(5):1421-1433. DOI: 10.4049/jimmunol.1800530. View

Lavalett L, Rodriguez H, Ortega H, Sadee W, Schlesinger L, Barrera L . Alveolar macrophages from tuberculosis patients display an altered inflammatory gene expression profile. Tuberculosis (Edinb). 2017; 107:156-167. DOI: 10.1016/j.tube.2017.08.012. View

Sigal G, Segal M, Mathew A, Jarlsberg L, Wang M, Barbero S . Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial. EBioMedicine. 2017; 25:112-121. PMC: 5704068. DOI: 10.1016/j.ebiom.2017.10.018. View

10.

Fanucchi S, Fok E, Dalla E, Shibayama Y, Borner K, Chang E . Immune genes are primed for robust transcription by proximal long noncoding RNAs located in nuclear compartments. Nat Genet. 2018; 51(1):138-150. DOI: 10.1038/s41588-018-0298-2. View

11.

Comas I, Coscolla M, Luo T, Borrell S, Holt K, Kato-Maeda M . Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat Genet. 2013; 45(10):1176-82. PMC: 3800747. DOI: 10.1038/ng.2744. View

12.

Caruso A, Serbina N, Klein E, TRIEBOLD K, Bloom B, Flynn J . Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J Immunol. 1999; 162(9):5407-16. View

13.

Amaral E, Costa D, Namasivayam S, Riteau N, Kamenyeva O, Mittereder L . A major role for ferroptosis in -induced cell death and tissue necrosis. J Exp Med. 2019; 216(3):556-570. PMC: 6400546. DOI: 10.1084/jem.20181776. View

14.

Kurtz S, Rossi A, Beamer G, Gatti D, Kramnik I, Elkins K . The Diversity Outbred Mouse Population Is an Improved Animal Model of Vaccination against Tuberculosis That Reflects Heterogeneity of Protection. mSphere. 2020; 5(2). PMC: 7160682. DOI: 10.1128/mSphere.00097-20. View

15.

Carvalho A, Amorim G, Melo M, Silveira A, Vargas P, Moreira A . Pre-Treatment Neutrophil Count as a Predictor of Antituberculosis Therapy Outcomes: A Multicenter Prospective Cohort Study. Front Immunol. 2021; 12:661934. PMC: 8284392. DOI: 10.3389/fimmu.2021.661934. View

16.

Nair S, Huynh J, Lampropoulou V, Loginicheva E, Esaulova E, Gounder A . expression in myeloid cells prevents immunopathology during infection. J Exp Med. 2018; 215(4):1035-1045. PMC: 5881474. DOI: 10.1084/jem.20180118. View

17.

Collins J, Jones D, Sharma A, Khadka M, Liu K, Kempker R . TCA cycle remodeling drives proinflammatory signaling in humans with pulmonary tuberculosis. PLoS Pathog. 2021; 17(9):e1009941. PMC: 8494353. DOI: 10.1371/journal.ppat.1009941. View

18.

Norris B, Ernst J . Mononuclear cell dynamics in M. tuberculosis infection provide opportunities for therapeutic intervention. PLoS Pathog. 2018; 14(10):e1007154. PMC: 6221360. DOI: 10.1371/journal.ppat.1007154. View

19.

Simmons J, Van P, Stein C, Chihota V, Ntshiqa T, Maenetje P . Monocyte metabolic transcriptional programs associate with resistance to tuberculin skin test/interferon-γ release assay conversion. J Clin Invest. 2021; 131(14). PMC: 8279582. DOI: 10.1172/JCI140073. View

20.

Pisu D, Huang L, Narang V, Theriault M, Le-Bury G, Lee B . Single cell analysis of M. tuberculosis phenotype and macrophage lineages in the infected lung. J Exp Med. 2021; 218(9). PMC: 8302446. DOI: 10.1084/jem.20210615. View